As of 2025-07-16, the Relative Valuation of Aurobindo Pharma Ltd (AUROPHARMA.NS) is 1,606.71 INR. This relative valuation is based on P/E multiples. With the latest stock price at 1,152.00 INR, the upside of Aurobindo Pharma Ltd based on Relative Valuation is 39.5%.
The range of the Relative Valuation is 1,517.14 - 2,172.67 INR.
| Range | Selected | |
| Trailing P/E multiples | 25.4x - 36.2x | 27.2x |
| Forward P/E multiples | 21.4x - 27.8x | 22.3x |
| Fair Price | 1,517.14 - 2,172.67 | 1,606.71 |
| Upside | 31.7% - 88.6% | 39.5% |
| Date | P/E |
| 2025-07-14 | 18.97 |
| 2025-07-11 | 18.76 |
| 2025-07-10 | 18.83 |
| 2025-07-09 | 19.04 |
| 2025-07-08 | 19.03 |
| 2025-07-07 | 19.70 |
| 2025-07-04 | 19.84 |
| 2025-07-03 | 19.31 |
| 2025-07-02 | 19.31 |
| 2025-07-01 | 18.93 |
| 2025-06-30 | 18.87 |
| 2025-06-27 | 18.74 |
| 2025-06-26 | 18.72 |
| 2025-06-25 | 18.68 |
| 2025-06-24 | 18.37 |
| 2025-06-23 | 18.30 |
| 2025-06-20 | 18.23 |
| 2025-06-19 | 17.99 |
| 2025-06-18 | 18.39 |
| 2025-06-17 | 18.49 |
| 2025-06-16 | 19.04 |
| 2025-06-13 | 19.13 |
| 2025-06-12 | 19.21 |
| 2025-06-11 | 19.44 |
| 2025-06-10 | 19.48 |
| 2025-06-09 | 19.33 |
| 2025-06-06 | 19.36 |
| 2025-06-05 | 19.35 |
| 2025-06-04 | 18.97 |
| 2025-06-03 | 19.05 |
| 2025-06-02 | 18.95 |
| 2025-05-30 | 19.16 |
| 2025-05-29 | 19.54 |
| 2025-05-28 | 19.06 |
| 2025-05-27 | 19.80 |
| 2025-05-26 | 19.69 |
| 2025-05-23 | 19.86 |
| 2025-05-22 | 19.78 |
| 2025-05-21 | 20.04 |
| 2025-05-20 | 19.90 |
| 2025-05-19 | 20.11 |
| 2025-05-16 | 20.03 |
| 2025-05-15 | 20.34 |
| 2025-05-14 | 20.35 |
| 2025-05-13 | 20.39 |
| 2025-05-12 | 20.08 |
| 2025-05-09 | 19.32 |
| 2025-05-08 | 19.28 |
| 2025-05-07 | 19.98 |
| 2025-05-06 | 20.11 |